← til store investorer
Behrenbruch (Christian P. Ph.D.) (Chief Executive Officer)
insider
I virksomheder i vores database 1
| Selskab | Andel | Aktier | Rapportdato |
|---|---|---|---|
| TELIX Pharmaceuticals Ltd | — | 21 396 941 | 2026-04-29 |
annonce